Literature DB >> 13608407

Gynecomastia; the origins of mammary swelling in the male: an analysis of 406 patients with breast hypertrophy, 525 with testicular tumors, and 13 with adrenal neoplasms.

N TREVES.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX/neoplasms; GYNECOMASTIA/etiology and pathogenesis; TESTES/neoplasms

Mesh：

Year:  1958        PMID： 13608407     DOI： 10.1002/1097-0142(195811/12)11:6<1083::aid-cncr2820110602>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Malignant tumors of the testes. Report of a case of nine year survival.

Authors:  C H GARVIN
Journal:  J Natl Med Assoc       Date:  1962-03       Impact factor: 1.798

2.  Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung.

Authors:  D Fairlamb; E Boesen
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

3.  Surgical treatment of primary gynecomastia in children and adolescents.

Authors:  Sebastian Fischer; Tobias Hirsch; Christoph Hirche; Jurij Kiefer; Maximilian Kueckelhaus; Günter Germann; Matthias A Reichenberger
Journal:  Pediatr Surg Int       Date:  2014-04-24       Impact factor: 1.827

4.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

5.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

Review 6.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.